Spire Wealth Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-55
Closed -$7.14K 2418
2025
Q2
$7.14K Buy
55
+51
+1,275% +$7.39K ﹤0.01% 1831
2025
Q1
$637 Sell
4
-2
-33% -$362 ﹤0.01% 2442
2024
Q4
$1.11K Hold
6
﹤0.01% 2347
2024
Q3
$1.27K Buy
+6
New +$1.04K ﹤0.01% 2067
2023
Q4
Sell
-100
Closed -$19.8K 2413
2023
Q3
$19.8K Hold
100
﹤0.01% 1505
2023
Q2
$32.5K Hold
100
﹤0.01% 1384
2023
Q1
$23.4K Hold
100
﹤0.01% 1556
2022
Q4
$25K Hold
100
﹤0.01% 1274
2022
Q3
$18K Hold
100
﹤0.01% 1371
2022
Q2
$18K Hold
100
﹤0.01% 1715
2022
Q1
$26K Hold
100
﹤0.01% 1702
2021
Q4
$23K Hold
100
﹤0.01% 2065
2021
Q3
$23K Hold
100
﹤0.01% 1800
2021
Q2
$19K Hold
100
﹤0.01% 1889
2021
Q1
$21K Buy
+100
New +$21.3K ﹤0.01% 2129

Other funds holding INSP

Spire Wealth Management's INSP Position: Q3 2025 in Review

Spire Wealth Management sold out of Inspire Medical Systems (INSP) in Q3 2025, closing a stake of 55 shares — an estimated $7.14K sold.

Spire Wealth Management first reported a position in INSP in Q1 2021 and held it in 15 quarters. The position peaked at $32.5K in Q2 2023. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

  • Spire Wealth Management reported no remaining Inspire Medical Systems position as of Q3 2025 after selling out during the quarter.
  • Spire Wealth Management sold 55 Inspire Medical Systems shares in Q3 2025, an estimated $7.14K.
  • Spire Wealth Management first reported a position in Inspire Medical Systems in Q1 2021 and held it in 15 quarters.
  • Spire Wealth Management's Inspire Medical Systems position peaked at $32.5K in Q2 2023.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on Spire Wealth Management's 13F filing for Q3 2025, filed 23 Oct 2025.